J&J and GSK Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Janssen, GlaxoSmithKline, and US WorldMeds Editor’s Note: This article was updated on a…

Fresenius Kabi To Expand Sterile Mfg Operations
By

By
Fresenius Kabi, a Lake Zurich, Illinois-headquartered specialty and generic pharmaceuticals company and a subsidiary of Fresenius KGaA, a Bad Homburg, Germany-headquartered healthcare group, plans to invest $100 million to expand…

Fresenius Kabi Opens Injectables Mfg Facility in Indonesia
By

By
Fresenius Kabi, a Lake Zurich, Illinois-headquartered specialty and generic pharmaceuticals company and a subsidiary of Fresenius KGaA, a Bad Homburg, Germany-headquartered healthcare group, is expanding its activities in Indonesia. PT…

Perrigo Completes Divestiture of API Business For $110 Million
By

By
Perrigo has completed its previously announced divestiture of its active pharmaceutical ingredient (API) business based in Israel to SK Capital, a New York, New York-based private investment firm focused on…

ImmunoVaccine, Leidos Expand Vaccine Pact
By

By
Immunovaccine, a Nova Scotia, Canada-headquartered clinical-stage immunotherapy and vaccine company, is expanding its collaboration with Leidos, a science and technology company, to develop preventative, peptide-based malaria vaccine candidates. The United…

Biogen, Alkermes Partners for MS Drug
By

By
Biogen and Alkermes have signed a license and collaboration agreement to develop and commercialize ALKS 8700, an oral, monomethyl fumarate small-drug molecule in Phase III development for treating relapsing forms…

EC Issues GMP Guidelines for Certain Advanced Therapies
By

By
The European Commission has issued a set of guidelines on good manufacturing practices (GMP) specific to advanced therapy medicinal products (ATMPs). ATMPs are medicines for human use that are based…

Cytovance in Biomanufacturing Supply Pact
By

By
Cytovance Biologics, an Oklahoma City, Oklahoma-based biologics contract manufacturer, has signed an agreement with Bexion Pharmaceuticals, a Covington, Kentucky-headquartered biotechnology company, to manufacture the protein component and active ingredient of…

Brammer Bio Launches Gene-Therapy Product Mfg Operations
By

By
Brammer Bio, a Lexington, Massachusetts-headquartered cell and gene therapy contract development and manufacturing organization, has completed renovations and has launched its late-stage clinical capacity and commercial-ready cGMP manufacturing site in…

Recipharm Equips Three Facilities for US Serialization
By

By
Recipharm, a Swedish contract development and manufacturing organization, has equipped three of its facilities with serialization capabilities in line with the US regulatory requirements. Its facilities in Brescia, Italy and…